Evidence map›Paper›PMID 39930566›Full record

Observational studyDiabetes, obesity & metabolism2025

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring.

Howard Wolpert, David Rodbard, Jie Xue, Jennal Johnson, Eyal Dassau

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03368807 (An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03368807 completednot on this map

An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors

TypeobservationalSponsorEli Lilly and CompanyRan2017 to 2018Enrolled79ConditionsDiabetes Mellitus, Type 1, Diabetes Mellitus, Type 2ArmsContinuous Glucose Monitoring, Insulin Lispro
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Howard WolpertBoston Medical Center, Boston, Massachusetts, USA.
David RodbardBiomedical Informatics Consultants LLC, Potomac, Maryland, USA.ORCID 0000-0002-5547-3564
Jie XueEli Lilly and Company, Indianapolis, Indiana, USA.ORCID 0000-0002-5056-6526
Jennal JohnsonEli Lilly and Company, Indianapolis, Indiana, USA.
Eyal DassauEli Lilly and Company, Indianapolis, Indiana, USA.

Funding

Eli Lilly and Company
6 · The paper itself

Abstract

aimsConnected insulin pens (CIPs) provide insulin dosing data that can be leveraged to drive improvements in glycaemic control. To realize this potential in routine care, insulin data need to be distilled into actionable insights for clinicians. We describe two algorithms for detecting glucose excursions using continuous glucose monitoring (CGM) data and then link excursions to CIP data to derive "insulin metrics" characterizing suboptimal bolus dosing practices. MATERIALS AND

methodsThis post hoc analysis used CGM and CIP data from a 12-week observational study (clinicaltrials.gov: NCT03368807) of 64 adults with type 1 or type 2 diabetes receiving multiple daily injection insulin therapy and glycated haemoglobin ≥8%. Two updated algorithms were applied to analyse glucose excursions associated with pre-meal boluses, missed bolus doses (MBDs), delayed boluses and correction boluses.

resultsGlycaemic metrics obtained using both algorithms were similar. Time in range (%TIR) was lower, and time above range (%TAR) and glycaemic variability (%GV) were higher, on days with MBDs. Compared with pre-meal boluses, delayed and correction boluses were followed by glucose excursions with larger change in glucose, longer duration with glucose >180 mg/dL, lower post-excursion %TIR and higher post-excursion %TAR; excursions following MBDs showed lower %TIR, higher %TAR and lower percent recovery. Glucose excursions were larger and longer when CGM was masked than when unmasked.

conclusionsThis analysis demonstrates "insulin metrics"-characterizations of insulin dosing behaviour derived from integrated CGM and CIP data-and provides a foundation for future work that will expand the understanding of an individual's insulin self-administration practices and improve clinical decision-making.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Hypoglycemic AgentsInsulinAdultAgedAlgorithmsContinuous Glucose MonitoringFemaleGlycated HemoglobinGlycemic ControlHumansInsulin Infusion SystemsMaleBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulincontinuous glucose monitoring (CGM)glycaemic controlhypoglycaemiainsulin therapyobservational study

Identifiers

PMID39930566
PMCPMC11964990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.